ConductScience.org, home

Paper99034

Platinum nephrotoxicity.

Madias NE and 1 other. Am J Med, 1978. Cited by 497 papers, by iCite.

Cite this record

ConductScience Library. Platinum nephrotoxicity. Papers, record 99034. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/99034

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Platinum nephrotoxicity.
PubMed
Journal
Am J Med
PubMed
Year
1978
PubMed
Publication types
Clinical Trial, Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S., Review
PubMed
Citations, by iCite
497
iCite
Relative citation ratio, by iCite
18.7
iCite
Revised in PubMed
2022-04-10
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Madias NEN E
2Harrington JTJ T

Source PubMed

Download CSV of authors

Topics22

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Acute Kidney InjuryMajor topic
CisplatinMajor topic
KidneyMajor topic
Kidney Tubular Necrosis, AcuteMajor topic
Animals
Callitrichinae
Clinical Trials as Topic
Dogs
Drug Evaluation, Preclinical
Haplorhini
Humans
Injections, Intravenous
Kidney Function Tests
Kidney Tubules
Kidney Tubules, Proximal
Macaca mulatta
Male
Mice
Neoplasms
Neoplasms, Experimental
Rabbits
Rats

Source PubMed

Download CSV of topics

Cited by119

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 497 citations.

PMIDTitleJournalYearIn PapersSource
42831533Quercetin Attenuates Cisplatin-Induced Nephrotoxicity While Enhancing Antitumor Efficacy in Gastric Cancer via Cell Type-Specific Modulation of the ERK1/2 Pathway.J Biochem Mol Toxicol2026https://conductscience.org/library/papers/42831533PubMed
41778253Prolonged Renal Dysfunction in Patients Undergoing Chemotherapy for Locally Advanced Esophageal Cancer: Treatment Implications and Risk Factors.Cancer Diagn Progn2026https://conductscience.org/library/papers/41778253PubMed
41592613Flopropione, a Cysteine Conjugate β-Lyase 1 Inhibitor, for Prevention of Cisplatin-Induced Nephrotoxicity: Protocol for a Randomized, Open-Label, Proof-of-Concept Phase 1 and 2a Trial.JMIR Res Protoc2026https://conductscience.org/library/papers/41592613PubMed
41288783Hydration practices during cisplatin administration: a national multicenter survey.Support Care Cancer2025https://conductscience.org/library/papers/41288783PubMed
40526606EPHX1 and ERCC2 polymorphisms are associated with cisplatin-induced nephrotoxicity and prognosis in Thai cancer patients.PLoS One2025https://conductscience.org/library/papers/40526606PubMed
39681358Remote organ cancer induces kidney injury, inflammation, and fibrosis and adversely alters renal function.Am J Physiol Renal Physiol2025https://conductscience.org/library/papers/39681358PubMed
39605909Predicting adverse drug event using machine learning based on electronic health records: a systematic review and meta-analysis.Front Pharmacol2024https://conductscience.org/library/papers/39605909PubMed
39494507Intraoperative hyperthermia is associated with increased acute kidney injury following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a retrospective cohort study.Ren Fail2024https://conductscience.org/library/papers/39494507PubMed
39192240Time-course analysis of cisplatin induced AKI in preclinical models: implications for testing different sources of MSCs.J Transl Med2024https://conductscience.org/library/papers/39192240PubMed
39022464The Use of Amiloride and Sodium-Glucose Cotransporter 2 Inhibitors in Cisplatin-Induced Hypomagnesemia: A Case Report and Review of the Literature.Cureus2024https://conductscience.org/library/papers/39022464PubMed
38714773Comparison of preventive effects of combined furosemide and mannitol versus single diuretics, furosemide or mannitol, on cisplatin-induced nephrotoxicity.Sci Rep2024https://conductscience.org/library/papers/38714773PubMed
38418143Evaluation of Prediabetes in Cisplatin-induced Nephrotoxicity in the Short Hydration Method: A Subgroup Analysis.In Vivo2024https://conductscience.org/library/papers/38418143PubMed
38410567
Cytoreductive surgery combined with hyperthermic intrathoracic chemotherapy for the treatment of thymic epithelial malignancies with pleural spread or recurrence (CHOICE): a study protocol for a prospective, open, single-arm study.
J Thorac Dis2024https://conductscience.org/library/papers/38410567PubMed
38148888The Effect of Donor Rat Gender in Mitochondrial Transplantation Therapy of Cisplatin-Induced Toxicity on Rat Renal Proximal Tubular Cells.Iran J Pharm Res2023https://conductscience.org/library/papers/38148888PubMed
37816823Risk factor analysis for cisplatin-induced nephrotoxicity with the short hydration method in diabetic patients.Sci Rep2023https://conductscience.org/library/papers/37816823PubMed
36528725Diabetes mellitus degenerates cisplatin-induced nephrotoxicity in short hydration method: a propensity score-matching analysis.Sci Rep2022https://conductscience.org/library/papers/36528725PubMed
36401337Capsaicin alleviates cisplatin-induced muscle loss and atrophy in vitro and in vivo.J Cachexia Sarcopenia Muscle2023https://conductscience.org/library/papers/36401337PubMed
35832084MiR-155 deficiency protects renal tubular epithelial cells from telomeric and genomic DNA damage in cisplatin-induced acute kidney injury.Theranostics2022https://conductscience.org/library/papers/35832084PubMed
35632435Renal Function Outcomes in Metastatic Non-Small-Cell Lung Carcinoma Patients Treated with Chemotherapy or Immune Checkpoint Inhibitors: An Unexpected Scenario.Vaccines (Basel)2022https://conductscience.org/library/papers/35632435PubMed
35436142The Effect of Intravenous Mannitol Combined With Normal Saline in Preventing Cisplatin-Induced Nephrotoxicity: A Randomized, Double-Blind, Placebo-Controlled Trial.JCO Glob Oncol2022https://conductscience.org/library/papers/35436142PubMed

See all 119 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/99034

GET https://conductscience.org/api/papers/v1/99034/cited_by?page=2